11.07.2015 Views

Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

He<strong>al</strong>th Technology Assessment 1997; Vol. 1: No. 4Chapter 6Prev<strong>al</strong>enceStudies of prev<strong>al</strong>ence f<strong>al</strong>l into two distinctgroups. In one group of studies, the investigatorsstudied the cases of fragile X syndromefound in institutions. In the absence of in<strong>for</strong>mationon the proportion of affected individu<strong>al</strong>swho are institution<strong>al</strong>ised, these studiescannot be used to estimate a population prev<strong>al</strong>ence.Non<strong>et</strong>heless, they do <strong>al</strong>low an estimateof the frequency of the disorder among individu<strong>al</strong>swith ment<strong>al</strong> handicap, which is useful<strong>for</strong> case-finding (see page 27). In a secondgroup of studies either multiple sources or asystematic m<strong>et</strong>hod of ascertainment was usedto obtain a more compl<strong>et</strong>e yield of cases in thewhole of a defined population.BiasThere is likely to be marked b<strong>et</strong>ween-studyvariability in the estimated prev<strong>al</strong>ence of fragileX syndrome owing to important differences instudy design. Those studies which are basedon a cytogen<strong>et</strong>ic diagnosis of fragile X syndromewill tend to yield higher estimates of prev<strong>al</strong>enc<strong>et</strong>han those using DNA m<strong>et</strong>hods. Studies thatinclude fem<strong>al</strong>es will tend to underestimateprev<strong>al</strong>ence if diagnostic testing is restrictedto institutions and speci<strong>al</strong> education<strong>al</strong> units.The relatively large number of mild cases mayescape d<strong>et</strong>ection. Studies that include a disproportionatenumber of children will <strong>al</strong>so tendto yield relatively low estimates. Diagnosis willbe delayed in individu<strong>al</strong>s in whom the clinic<strong>al</strong>features of fragile X syndrome are not apparentuntil puberty; indeed, in some individu<strong>al</strong>s theintellectu<strong>al</strong> deficit may not be noticed untilthey are of secondary school age.Frequency in thement<strong>al</strong>ly handicappedThe frequency of fragile X syndrome in institution<strong>al</strong>isedm<strong>al</strong>es was examined in ten studies (Table 8).Of the 2019 m<strong>al</strong>es tested in <strong>al</strong>l the studies combined,6% were found to be affected. However, thefrequency varied greatly b<strong>et</strong>ween studies and theh<strong>et</strong>erogeneity may mean that the over<strong>al</strong>l frequencyis not a reliable estimate of the true rate. TheTABLE 8 Frequency of fragile X syndrome among m<strong>al</strong>esin institutions: results of ten studiesStudy Selection Number <strong>Fragile</strong> Xcriteria * (%)Finland UA 150 6 (4)Kähkönen <strong>et</strong> <strong>al</strong>, 1983Germany All 242 15 (6)Froster-Iskenius<strong>et</strong> <strong>al</strong>, 1983USA, Boston UA 44 6 (14)Paika <strong>et</strong> <strong>al</strong>, 1984Belgium UA 354 57 (16)Fryns <strong>et</strong> <strong>al</strong>, 1984cJapan All 305 11 (4) †Arinami <strong>et</strong> <strong>al</strong>, 1986Hofstee <strong>et</strong> <strong>al</strong>, 1994UK UA 100 7 (7)Primrose <strong>et</strong> <strong>al</strong>, 1986USA, Colorado UA 267 7 (3)Hagerman <strong>et</strong> <strong>al</strong>,1988aSicily All 155 12 (8)Neri <strong>et</strong> <strong>al</strong>, 1988USA,Tennessee UA 201 4 (2)Butler & Singh, 1993Poland All 201 6 (3) †Mazurczak <strong>et</strong> <strong>al</strong>, 1996All 2019 131 (6)† All m<strong>al</strong>es were tested except in studies selecting those withunknown ment<strong>al</strong> impairment of a<strong>et</strong>iology (UA).* Confirmed by DNA an<strong>al</strong>ysis.variability was due to a number of differences instudy design; viz:• admission patterns <strong>for</strong> the institution• compl<strong>et</strong>eness of ascertainment due topatient and parent<strong>al</strong> non-compliance withdiagnostic testing• selection criteria <strong>for</strong> testing (e.g. in somestudies only those with typic<strong>al</strong> features of fragileX syndrome were tested, while in otherseveryone was tested)• definition of the denominator population.21

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!